Beståndsuppgifter: Secondary donor-derived CD19 CAR-T therapy is safe and efficacious in acute lymphoblastic leukemia with extramedullary relapse after first autologous CAR-T therapy

Laddar…

Visa i EDS

Sparad:

Källa:

Journal of Zhejiang University-SCIENCE B: Biomedicine & Biotechnology. 23(10):876-880

Databas:

Springer Nature Journals